Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121902567 | 12190256 | 7 | F | 20160205 | 20160706 | 20160318 | 20160707 | EXP | US-BAYER-2016-026100 | BAYER | 80.00 | YR | E | M | Y | 80.73000 | KG | 20160707 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121902567 | 12190256 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | 200 MG, BID | Y | BXH35J1 | 21923 | 200 | MG | FILM-COATED TABLET | BID | ||||
| 121902567 | 12190256 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | UNK | Y | 21923 | FILM-COATED TABLET | ||||||||
| 121902567 | 12190256 | 3 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 200 MG, BID | Y | 21923 | 200 | MG | FILM-COATED TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121902567 | 12190256 | 1 | Hepatocellular carcinoma |
| 121902567 | 12190256 | 2 | Hepatocellular carcinoma |
| 121902567 | 12190256 | 3 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121902567 | 12190256 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121902567 | 12190256 | Abdominal pain upper | |
| 121902567 | 12190256 | Abnormal loss of weight | |
| 121902567 | 12190256 | Arteriogram | |
| 121902567 | 12190256 | Asthenia | |
| 121902567 | 12190256 | Blister | |
| 121902567 | 12190256 | Blood pressure increased | |
| 121902567 | 12190256 | Brachytherapy to liver | |
| 121902567 | 12190256 | Decreased appetite | |
| 121902567 | 12190256 | Diarrhoea | |
| 121902567 | 12190256 | Dysphonia | |
| 121902567 | 12190256 | Fall | |
| 121902567 | 12190256 | Liver function test abnormal | |
| 121902567 | 12190256 | Rash | |
| 121902567 | 12190256 | Urinary incontinence | |
| 121902567 | 12190256 | Vessel puncture site swelling | |
| 121902567 | 12190256 | Vomiting | |
| 121902567 | 12190256 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121902567 | 12190256 | 1 | 20160201 | 20160317 | 0 | |
| 121902567 | 12190256 | 2 | 201604 | 0 |